HRSA Weighs Next Steps On 340B 'Mega-Reg' After Court Overturns Orphan Drug Suit

A HRSA official told stakeholders Tuesday (June 10) the agency is weighing the impact of a recent court decision that some say could limit the agency's ability to proceed with a highly anticipated 340B "mega-reg" laying out the parameters of the drug discount program.

Read more: HRSA Weighs Next Steps On 340B 'Mega-Reg' After Court Overturns Orphan Drug Suit


Download PDF Share Back To Listing
Loading data